ATP - NLRP3 Inflammasome Inducer

Adenosine 5'-triphosphate disodium salt

SPECIFICATIONS

Specifications

Source
Adenosine triphosphate disodium salt
CAS number
987-65-5
Chemical formula

C10H14N5O13P3 •2Na

Molecular weight
551.14 g/mol
Working concentration

5 mM

Purity
≥99.0% (HPLC)
Solubility

400 mg/ml (725 mM) in water

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    ATP
  • Cat code: 
    tlrl-atpl
  • Quantity: 
    1 g

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

Extracellular ATP is a key danger-associated molecular pattern (DAMP) that is able to acitvate the NLRP3 inflammasome. It triggers the opening of the non-selective cation channel of the purinergic P2X7 receptor, followed by the subsequent alteration of the intracellular K+ concentration [1]. 

The NLRP3 inflammasome is an intracellular multi-protein complex that plays a central role in innate immunity. It is activated by a two-step process. A first signal (‘priming’) is provided by pathogen-associated molecular patterns (PAMPs) or cytokines. It allows the transcriptional upregulation of key inflammasome actors and the post-translational modification of NLRP3 . The second signal (‘activation’) is provided by a wide array of stimuli including microbial toxins, endogenous molecules or crystalline substances. The current paradigm is that NLRP3 does not bind directly to these molecules. Rather it senses downstream cytosolic stress signals such as K+ efflux. This  triggers inflammasome multimerization and pro-caspase-1 maturation. Proximity-induced autolytic activation of caspase-1 leads to the formation of gasdermin D (GSDMD) pores at the cell surface, allowing IL-1β/IL-18 and alarmin secretion, and ultimately, pyroptosis [3,4].

 

References:

1. Amores-Iniesta J, et al., 2017. Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection. Cell Rep.;21(12):3414-3426.
2. Swanson K.V. et al., 2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19:477.
3. Groslambert M. & Py B. 2018. Spotlight on the NLRP3 inflammasome pathway. J. Inflamm. Res. 11:359.

Chemical structure of ATP:

Chemical structure of ATP

DOCUMENTS

Documents

ATP

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?